Scientific Company Directory

Scientific Company Directory

The latest research, products, and discoveries from the science industry’s leading companies and company divisions.

NEW

Scientific Products

From innovative tools to essential equipment and supplies, find everything you need to advance your research on our new Scientific Products page.

Search Scientific Products
  • ALL
    • |
  • A
    • |
  • B
    • |
  • C
    • |
  • D
    • |
  • E
    • |
  • F
    • |
  • G
    • |
  • H
    • |
  • I
    • |
  • J
    • |
  • K
    • |
  • L
    • |
  • M
    • |
  • N
    • |
  • O
    • |
  • P
    • |
  • Q
    • |
  • R
    • |
  • S
    • |
  • T
    • |
  • U
    • |
  • V
    • |
  • W
    • |
  • X
    • |
  • Y
    • |
  • Z

    • Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.

    Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. We provide contract biologic R&D and manufacturing services to the diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. We also assist clients with rapidly developing, manufacturing, and commercializing point of care lateral flow, flow through, and ELISA assays. Our goal is to be a trusted source for all your assay development and manufacturing needs. With decades of experiences and our unique technologies, Creative Diagnostics is committed to providing its customers the highest quality products and services.
    Leica Microsystems is one of the market leaders in microscopy and scientific imaging. The company develops highly advanced instruments for the analysis of microstructures and nanostructures - increasingly harnessing the power of machine learning, automation, and data analytics to provide greater insights to scientists than ever before.
    Helping to accelerate the next breakthrough in drug discovery, diagnostics and basic research.

    Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure.​
     
    Revvity is pushing the limits of what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.​
     
    With a robust global network and localized agility, we serve a diverse range of organizations from pharmaceutical and biotech, to clinical labs, academia, and governments.​
     
    Together with our customers and partners, we are united in impact, embracing the impossible to improve lives everywhere.

    The Sartorius Group is a leading international partner of biopharmaceutical research and the industry. With innovative laboratory instruments and consumables, the Group's Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently.

    Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields. 

    PHC Corporation of North America, located in Wood Dale, IL, is a leader in laboratory equipment for the biopharmaceutical, life sciences, academic, healthcare and government markets. Product lines under the PHCbi brand include the space saving and energy efficient VIP® ECO and TwinGuard® ultra-low temperature freezers, cryogenic and biomedical freezers, pharmacy and high-performance refrigerators, cell culture CO2 and multigas incubators, and Drosophila/plant growth chambers. PHC Corporation of North America is a subsidiary of PHC Holdings Corporation, Tokyo, Japan, which is a global healthcare company that develops, manufactures, sells, and services solutions across diabetes management, healthcare solutions, diagnostics and life sciences. For information call PHC Corporation of North America at 800-858-8442, visit www.phchd.com/us/biomedical or email info@us.phchd.com

    About Phenomenex

    Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in academic, pharmaceutical, biotech, environmental, clinical research, government, and industrial laboratories. From drug discovery and pharmaceutical development to food safety and environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve human health and well-being. Phenomenex is an operating company within the Life Sciences group of Danaher Corporation.

    For more information, please visit www.phenomenex.com and follow the company's blog at www.scienceunfiltered.com

    Beckman Coulter Life Sciences is a leading developer of scientific research technologies that primarily serve the academia and pharmaceutical markets. The company also develops and manufacture solutions for clinical research and for applied markets such as agricultural, food and beverage, gas and oil, aerospace, and several others.

    For over 55 years, INFORS HT has been developing and producing high-tech solutions for biotechnology, biopharmaceuticals, food technology, agricultural technology, and research institutes worldwide. Our areas of competence cover the entire culture process, from screening to process development to production. We are proud to be one of the best in the field of specialists for bioreactors, shaker incubators and bioprocess control software. Much has changed since the company was founded in 1965. The Spirit of INFORS HT, however, remains the same. In keeping with our company creed— "We firmly believe you can make anything better"—we commit ourselves every day to simplifying our biotechnology customers' workflows using the most modern technologies available.

    Olink® Proteomics, part of Thermo Fisher Scientific is a global biotechnology company dedicated to providing advanced products and services that enable new discoveries into human health and disease. Olink's innovative solutions deliver highly sensitive, precise, and multiplexed protein quantification, giving scientists the power to investigate complex biological processes with precision.

    Trusted by leading academic institutions and top pharmaceutical companies worldwide, Olink is committed to supporting researchers globally in their pursuit of improving human health. Headquartered in Uppsala, Sweden, Olink has offices in North America, Asia, and Europe.

    BMG LABTECH is a leading global manufacturer of innovative, high-quality, and reliable microplate reader instrumentation.

    At Stago, we work with you to design a comprehensive hemostasis solution to fit the unique needs of your laboratory. Our unique approach focuses on improving patient outcomes and reducing the overall cost of care. Rest assured with reliable results from our standardized testing platforms. Expert support services combined with a complete menu of routine and specialty assays enable you to focus on your patients while we focus on you.

    Sapio Sciences' mission is to improve lives by accelerating discovery, and because science is complex, Sapio makes technology simple. Sapio is a global business offering an all-in-one science-aware (TM) lab informatics platform combining cloud-based LIMS, ELN, and Jarvis data solutions.

    Sapio serves some of the largest global and specialist brands, including biopharma, CRO/CDMOs and clinical diagnostic labs across NGS genomic sequencing, bioanalysis, bioprocessing, chemistry, stability, histopathology, and in vivo studies.

    Customers love Sapio's platform because it is robust, scalable, and with no-code configuration, can quickly adapt to meet unique needs. For more information, visit www.sapiosciences.com and follow us on LinkedIn.

    Agilent (www.agilent.com) is a leader in life sciences, clinical research, diagnostics and applied chemical markets. With over 11,000 employees worldwide, the company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent's expertise and trusted collaboration give them the highest confidence in our solutions. Agilent focuses its expertise on six key markets, where we help our customers achieve their goals: • Food: Agilent products can help ensure that our global food supply is free of contaminants-whether chemical, viral, bacterial or microbiological • Environmental and Forensics: From pesticides to pharmaceutical residues to trace metals, Agilent provides fast, accurate and sensitive analytical methods for monitoring contaminants affecting quality of life • Pharmaceutical: Agilent has one of the broadest solutions portfolios of any company serving the pharmaceutical industry • Diagnostics: Agilent's reliable diagnostic products give doctors the information they need in the fight against cancer and other diseases • Chemical and Energy: The world runs on energy, and energy companies need to locate, extract and refine fuels efficiently and cost-effectively • Clinical Research: Most life sciences and clinical research is done at top-tier universities, with funding from governments around the world

    At MaxCyte, we share your passion for the discovery, development, and manufacturing of next generation therapies, harnessing the power of living cells to transform lives. 

     

    We know that every research journey is full of challenges, but we believe that transfecting cells shouldn’t be one of them. With over 20 years of cell engineering expertise using our best-in-class electroporation technology, we’ve perfected the art of the cell-engineering workflow. We want to share this with you to enable your pioneering research and help you to chart your most direct course to success.

     

    MaxCyte is the technology of choice for cell-engineering experts, driving a new generation of cell-based therapies. We have collaborated in many clinical trials driven by leaders in pharma and biotech to develop treatments for an expanding range of indications, including cancer, central nervous system disorders, and rare genetic diseases. 

    Molecular Devices is one of the leading providers of high-performance bioanalytical measurement solutions for the life science and biopharmaceutical research markets. The company's integrated hardware and software solutions enable start-to-finish automated workflows for cell line development, 3D biology and drug screening.

    Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.

     

    QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular information. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are then used to make these isolated biomolecules visible and ready for interpretation. QIAGEN markets more than 500 products around the world, selling both consumable kits and automation systems to customers through four customer classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research).

    Founded in 2002 and listed on the Hong Kong Stock Exchange in 2015, GenScript has an established global presence across Greater China, North America, the EU, and Asia Pacific. Today, over 300,000 customers from over 160 countries and regions around the world have used GenScript’s premier, convenient, and reliable products and services. GenScript currently has more than 5,000 employees globally, 33% of whom hold master’s and/or Ph.D. degrees. In addition, GenScript has a number of leading commercial technologies developed in the fields of synthetic biology, immunotherapy, antibody design, chemical synthesis and bioinformatics, including more than 100 patents and over 270 patent applications. As of June 2022, GenScript's products and services have been cited by 74,700 scientific papers worldwide. GenScript is committed to striving toward its vision of being the most reliable biotech company in the world to make humans and nature healthier through biotechnology.

    Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare - a strategy that aims to fit the right treatment to each patient in the best way possible.
    Sony Biotechnology Inc. is dedicated to helping researchers working across different life science disciplines to achieve the best scientific results. By leveraging Sony's vast know-how in electronics innovation and design we offer next-generation cell analysis systems to accelerate your discoveries. Our goal is to bring a unique perspective to the flow cytometry tools required for in-depth single cell isolation and analysis. With our core expertise in automation and software development we hope to enable discovery research across immunology, oncology, cell biology and microbiology.
    BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help improve patient outcomes, improve the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to better diagnose disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com.
    Automata was founded with a clear aim: to unlock human potential with automation. Through our collaboration with some of the world's leading pathology labs, we've developed the most comprehensive lab automation platform on the market. By simplifying environments and empowering people, Automata enables labs to scale with precision and creates new opportunities for scientists to accelerate innovation.

    SOPHiA GENETICS is a health tech company democratizing Data-Driven Medicine (DDM) to improve health outcomes and economics worldwide. By unlocking the power of new-generation health data for cancer and rare disease management, the SOPHiA DDMTM platform allows clinical researchers to act with precision and confidence. The company’s innovative approach and patented machine learning-based algorithms enable a community of more than 750 institutions to share knowledge, fostering a new era in healthcare.

    FUJIFILM Irvine Scientific is a worldwide leader in the innovation and manufacture of cell culture media, reagents, and medical devices for researchers and clinicians. The company provides unrivalled service and quality to scientists working in cell therapy and regenerative medicine, assisted reproductive technology and cytogenetics, and industrial cell culture for the large-scale production of biotherapeutics and vaccines. FUJIFILM Irvine Scientific adheres to both ISO and FDA regulations and operates dual cGMP manufacturing facilities in California, USA and Tokyo, Japan. The company’s consultative philosophy combined with expertise in cell culture and compliance provides customers with unique capabilities and support. For over 50 years FUJIFILM Irvine Scientific has remained uniquely flexible and focused on media while becoming a strategic global leader in media products and services.

    Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 115,000 colleagues serve people in more than 160 countries.

    MicroGenDX specializes in low-cost, highly accurate qPCR + NGS microbial DNA diagnostics - providing answers where cultures or PCR alone have failed.

    Applied BioCode is a Molecular Diagnostic company that is commercializing a unique multiplexing technology with broad use in clinical diagnostics, life science research, personalized medicine and the AgBio field. Our Barcoded Magnetic Bead (BMB) is a breakthrough "digital" technology enabling the simultaneous analysis of up to 4,096 DNA/protein tests from a single sample. The BMB is manufactured by a highly reproducible and scalable semiconductor process. When BMB technology is married with biotechnology, it becomes a very flexible and powerful bioassay platform with the advantages of high throughput, enhanced accuracy and affordability. BMB can be used in a wide variety of biological applications, such as routine clinical diagnostics, genetic analysis, biomarker validation, drug resistance genotyping and drug discovery. The technology outperforms the market-leading bead-based system in number of plex, barcode classification accuracy and ease-of-use. The technology is proven, and the company has licensed the technology to many companies in IVD, life science research and AgBio

    As a well-established leader in the Medical OEM industry, Pall MEDICAL designs, develops, and manufactures membranes to be used as components for medical and healthcare devices. Pall MEDICAL's mission is to provide their customers with the highest quality membranes allowing them to develop and manufacture their own medical devices.

    Learn more at https://www.pall.com/en/medical/oem-membranes-filtration.html 

    View Pall MEDICAL resources at https://www.pall.com/en/medical/resource-hub.resource-hub.tag1.OEM%20Membrane%20Filtration.tag3.html? 

    For over 30 years, Miltenyi Biotec has been a leader in the development of products that empower the advancement of biomedical research and enable cell and gene therapy. We provide innovative tools to help with your sample preparation, cell isolation, cell culture, and cell analysis needs. Our solutions are designed to support everything from basic research to translational research and clinical application for immunology, stem cell biology, neuroscience, and cancer.

    DiaSorin Molecular LLC manufactures and distributes molecular diagnostic products worldwide. Our Simplexa® molecular kits include HSV 1 & 2, Flu A/B & RSV, COVID-19, Bordetella, VZV, Group A Strep, GBS, C. difficile and our latest: SARS-CoV-2 Variants (RUO)*. Additionally, our menu includes over 65 primer pairs for laboratory developed tests. Simplexa® products are designed for use on the LIAISON® MDX, a real-time PCR instrument, which has the capability of running either an 8 well or 96 well disc. This provides an ideal platform to accommodate all volume testing needs. *For Research Use Only. Not for use in diagnostic procedures.

    NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications. NanoString's products are based on a novel digital molecular barcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis. In 2010, the company launched new applications for the system to support microRNA analysis and copy number variation detection, and in 2013 launched Prosigna®, its first in vitro diagnostic product for prognosis of early stage breast cancer. Organizations performing cancer research, biomarker validation and screening, and next-generation sequencing validation are rapidly adopting the nCounter® Analysis System. By providing simple, multiplexed digital profiling of single molecules, the NanoString platform represents a natural, digital downstream companion to next-generation sequencing and enables researchers to embark on studies that were previously inconceivable. Leading researchers and institutions are finding that NanoString's nCounter system provides the ideal platform on which to validate their discoveries and translate them into clinically useful diagnostic assays. The nCounter system is uniquely positioned to support translational research because it provides more reproducible results than methods requiring amplification, and generates high-quality data from the difficult sample types common in clinical research, including Formalin-Fixed Paraffin-Embedded (FFPE) tissues. In addition to continuing to extend the applications for the nCounter system in the discovery, target validation and routine testing segments of the genomics research market, the company's goal is to become the platform of choice for diagnostic testing based on multiplexed gene signatures that can be offered in hospitals and pathology laboratories worldwide, following appropriate regulatory approvals. These two synergistic areas of business focus provide researchers with a seamless transition from discovery to diagnostics.
    Eppendorf is a leading life science company that develops and sells instruments, consumables, and services for liquid-, sample-, and cell handling in laboratories worldwide. Its product range includes pipettes and automated pipetting systems, dispensers, centrifuges, mixers, spectrometers, and DNA amplification equipment as well as ultra-low temperature freezers, fermentors, bioreactors, CO2 incubators, shakers, and cell manipulation systems. Consumables such as pipette tips, test tubes, microtiter plates, and disposable bioreactors complement the range of highest-quality premium products. Eppendorf products are most broadly used in academic and commercial research laboratories, e.g., in companies from the pharmaceutical and biotechnological as well as the chemical and food industries. They are also aimed at clinical and environmental analysis laboratories, forensics, and at industrial laboratories performing process analysis, production, and quality assurance.
    SCIEX has led the field of mass spectrometry and capillary electrophoresis for over 50 years, pioneering innovative solutions for the precision detection of quantification of molecules. Our products and services have supported thousands of scientists and influenced life-changing research that has positively impacted the lives of people around the world.
    Luminex's mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, and food safety. We accelerate reliable answers while simplifying complexity and delivering certainty with a seamless experience.
    MilliporeSigma is the U.S. life science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company in healthcare, life science and performance materials. Our life science focus areas include advanced laboratory water purification, filtration, chromatography, chemistry, CRISPR gene editing, antibody technologies, cell biology, DNA & RNA oligos, biomarker detection, live cell analysis, environmental monitoring, and support for clinical, diagnostic, and pharmaceutical development and manufacturing. Find our broad portfolio of 300,000 products, an expansive global footprint and an industry-leading eCommerce platform at SigmaAldrich.com.
    The landscape of the life sciences industry is as vast and varied as the professionals who work in it. Some online resources aim to serve the entire space.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Illumina is transforming human health as the global leader in sequencing and array-based technologies. Illumina's flexible and scalable sequencing systems support and enable a wide range of single-cell sequencing applications, from low-throughput deep interrogation of rare cell populations to high-throughput profiling of tissues. For more information, please visit www.illumina.com.